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A monoclonal antikeratin antibody, EKH4, was pro-
duced from a h ybridoma cell line which was established 
by fusing P3X63SAg8 mouse myeloma cells with spleen 
cells of mice immunized with human trichilemmoma 
cell s. lmmunoblot analysis showed that EKH4 antibody 
r eacts predominantly with 50 kiloda lton keratin poly-
peptide in normal epidermis. By indirect immunofluo-
rescence a nd immunoperoxidase t echniques, EKH4 an-
tibody r eacted with the lowe r 2-3 cell laye rs of the 
epidermis as w e ll as most cells of pilose baceous follicle 
of human and animal skin. Tumor cells of human basal 
cell e pitheliomas and squamous cell carcinomas were 
a lso staine d with this antibody . The staining was much 
more regular a nd intense compared with an available 
monoclonal antikeratin antibody, AEI. In the lesion of 
epidermal proliferative disorder s, such as psoriasis and 
actinic k e r atosis, the e n t ire epidermis ins tead of the 
lower layers was s t a ine d w ith EKH4 antibody . Normal 
skin overlying or adjacent to epithelial tumors also 
showe d positive staining in the entire epidermis. By 
using indirect immunoperoxidase technique, EKH4 also 
s tained a lcohol-fixed, paraffin-embedded tissue sec-
tions . 
It ha!'; bee n shown t hat t he tonofil ame nts in the cytoplasm 
o f mamma li a n keratin ocytes a re composed of seve ra l ke ratin 
po lypeptides of 40- 70 ki loda lto ns (kd) (1- 4) . Because t he dif-
ferent keratin po lypeptides a re not identica l a n t igeni ca lly, an-
libocl ie. t hat react o nly w it h ce rta in keratin p o lypeptide(s ) have 
been repo rted [5,6 1. Antibod ies of s uc h hi gh specific ity could 
he produced e ithe r by U!'; in g purifi ed ke ratins o f ce rta in molec-
ul a r s pec ie!'; a nd immunizin g a nim a ls (conve nt ion a l po lyclo na l 
met hod) 101 o r by us ing rathe r heterogeneous ke ratin s pecies 
to immunize a nima ls a nd ta kin g advantage o f hybridoma tec h-
no logy to se lect spec ific monoclo na l a n t ibodies that react with 
o nly ce rtain ke ratin po lypeptide(s) [6). O ne o f t hese a n t ibodies, 
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Abbreviations: 
B E: basal cell epithelioma 
DAB: 3,:1' -diaminobenzidine 
ELISA: enzyme-linked immunosorhent assay 
kd: kiloda ltons 
PAP: peroxidase-a nt iperoxidase 
PBS: phosphate-buffered sa li ne 
PMA: peroxidase microassay 
SCC: squamous ce ll ca rcinoma 
SDS-PAGE: sodium dodecyl sulfate-polyacrylam ide gel elect ro-
phoresis 
TL: trichilemmoma 
AEl, fo r example, stains t he basal cell layer in t he norma l 
huma n epidermis immuno histochemically a nd has been used 
to a na lyze ke ratins in diseases [7] . 
Monoclonal a ntibodies have severa l advan tages over p o ly-
clonal a nt ibodies: ( 1) The a n tigen recognized by monoclonal 
a n t ibody is usua lly (if not a lways) a s m a ll , spec ific molecule 
a nd, t here fo re, t he a n t ibody is usua lly mo nospec ific; (2) speci -
fi c ity a nd quality a re unifo rm a nd not variable from batch to 
batc h; (3) the supply is perm a nen t as lo n g as t h e hybrido m a 
cell line is co nt inued ; and (4) production o f a la rge quantity of 
a n antibody o f unifo rm s pecificity is possible. These c haracter-
ist ics a re particula rly important when a mul ticenter study or 
clinica l t ria l of o ne particular a n t ibody is pla nned . 
In t he presen t study, we e mployed hybridom a techno logy 
a nd prod uced a new m on oclo na l a ntikerat in EKH4 a n t ibody 
wh ic h s hows a unique staining pattern in normal epidermis. 
C ha racterization by immunoblot technique, a ppli catio n in t u -
mor study, and applicat ion in study ing t he exp ressio n of t h e 
ant ige n in norm a l as well as disease ep idermis a re also described 
in t hi s report. Th is a n t ibody could a lso recognize t he a n t igen 
in a lco ho l-fixed, paraffin -embedded t issues. 
MATERIALS AND METHODS 
Immunization and Cell Fusion 
Human t richilemmoma (TL) cell line which was established from a 
scalp tumor of a pat ient in 1979 [8] and maintained in our laboratorv 
for 3 years was used as the immunogen [9]. Eight-week-old BALB/~ 
mice were immunized wit h 3 X 106 TL cells in 0.5 ml phosphate-
buffered saline (PBS) mixed with 0.5 ml Freund's complete adjuva nt 
by i.p. injection on day 0 and with 2 X 106 cells by i.v. injection on day 
14 a nd sac rificed on day 17 for ce ll fusion. Approximately 108 spleen 
ce lls from immunized mice were fused with 107 P3X63Ag8 mouse 
myeloma cells [10] by standard technique [11 ,12]. Cells were suspended 
in selection medium (HAT medium) and seeded to each of 700 wells of 
96-well fla t -bottom plates (Costar, Cambridge, Massachusetts). 
Sc reenings 
Antibodies were tested by both enzyme-linked immunosorbent assay 
(EL ISA) and a newly developed perox idase microassay (PMA). For 
both methods, 2 x 10' TL cells were cul tured in each well of a 96-well 
plate for 24 h and were fixed with acetone:methanol (1:1 , - 30"C). An 
ELISA was performed using a 1-lybridoma Screening Ki t (Bethesda 
Research Laborato ries, Rockville, Maryland) . For PMA, 50 Ill of hy-
bridoma culture supernate was appl ied to each we ll in which TL cells 
were plated, and incubated for 60 min at room temperature. After 
washing, 1:10 di lu ted perox idase-conjugated goat ant imouse lgG anti -
body (TACO, Inc., Burlingame, Calfiornia) was added and incubated 
for 30 min at room temperature. After washing, 0.05% DAB (3,3 ' -
diaminobenzidine, Sigma) with O.Ol % hydrogen peroxide was added for 
3- 5 min. The reaction was stopped by fillin g up each well with water. 
Each well was examined under a microscope for positive ly stained TL 
cells. This method enabled us to observe subcellular staining patte rns 
of the antibodies in addition to staining intensit ies. 
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Production. of EKH4 Antibody 
A hybridoma clone which produces a monoclonal ant ikeratin anti-
body EKH4 was selected from 440 clones. The hybridoma was cloned 
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twice by limi t in r: dilution met hod 11 :1 1 a nd producing EKH4 a ntibody 
co n sistently fo r more than 2 yea rs in t issue culture. 
Specimens 
Fresh tissues: The biopsy, surgica lly removed fresh tissues, or au-
topsy specimens were embedded in O. C.T. Compound (Lab-Tek Prod-
ucts, Naperville, Illinois) and snap-frozen in liquid nitrogen. Human 
t issues used fo r con( rol: 7 normal skins (head, face, a rm , palm , chest, 
back, axillae). !i normal mucosa (lip, tongue, gingiva, bucca, esophagus), 
1 g ingiva with chro nic inflammation, 1 melanoma, !.lentigo ma ligna, I 
nevus ce ll nevus, 1 gra nula r ce ll myoblastoma, l dermatofibrosarcoma 
protuberans. 2 dermatofibromas, 1 Kaposi's sa rcoma, and 2 psorias is. 
Huma n cuta neous epithelia l tumors: 2:3 basal ce ll epitheliomas (BCE, 
1 s cle rosing, 3 superficia l, 2 adenoid, 2 keratinous, and 15 solid types) 
including 3 c<~ses from Moh's surgery, 4 squamous ce ll ca rcinomas 
(SCC, 2 grade lll , 2 grade II ), 1 leukoplak ia (o ra l mucosa) , 2 acti nic 
k e r atos is, and 4 seborrheic keratosis. Mouse tissues: skin , ora l mucosa, 
esop hagus, t hymus, bladder, vo lu ntary muscle, live r, kidney (one each). 
Alcohol-fixed, paraffin -embedded human tissues : Eleven BCEs (2 
sc le rosing, 1 superficia l, l adenoid, 1 keratinous, 6 so lid types). 3 SCCs, 
a nd 1 Bowen's disease. 
Tissu e cu.ltured human. cell lines: TL, SCC (COL0-16), 2 breast 
ca rc inomas (13T 20, MCF -7), stomach ca rcinoma, 2 mela nomas {l(Hm-
1, A -375), neuroblastoma (lMR-32), gliobl as toma (A -172), and normal 
s kin fibroblast (F I3X6) . 
I mmu noflu urescence Study 
No nfi xed. 4 11m-thick frozen sections were incubated wi th EKH 4 
a n t ibody ( 1:1 00 diluted asc ites) at 37"C for 30 min . After rinsing with 
PBS, the sec tions were incubated with 1:20 di lu ted fluorescein isothio-
cyan ate-conjugated goat antimouse lgG (Cappel Laborato ries, Coch-
ra n v ille, Pennsy lva nia) at 37"C for 30 min . T he sec tions were rinsed 
w ith PBS, moun ted in para-phenylenediami ne mounting buffer [14]. 
.. ~-- ....; ... 
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and observed under a Zeiss Photomicroscope II equipped wi th fluores-
cence microscope opt ics. Some sections were incubated with AEl 
ant ibody (k indly provided by Dr. T .-T. Sun, Departments of Derma-
to logy and Pharmacology, New York University School of Medicine) 
[6] (1:50 diluted) instead of EKH4 antibody for comparative studies. 
For control studies, cont rol asc ites were substi tuted for EKH4 or AE I 
ant ibody. Tissue-cultured cells were grown on tissue-culture chamber( 
slides (Lab-Tek), fix ed with acetone-a lcohol and stained by the same 
method. 
l m.m.unoperoxidase Study 
Alcohol (70% ethanol)- fix ed, paraffin-embedded sect ions were de-
paraffini zed and endogenous peroxidase activity was blocked 115]. The 
sections were incubated with EKH4 ant ibody followed by perox idase-
conjugated goal antimouse IgG (1:10 diluted) at room temperature fo r 
30 min. Afte r rinsing with PBS, DAB reaction was carried out IJ 6]. 
Binding of EKH4 Antibody to Epidermal K eratin by l mm.unoblotting 
Kerati ns of t he living laye r were extracted from hu man abdomi nal 
skin obta ined from autopsy 16J . T he kera t ins were separated on one-
dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
(SDS -PAGE) acco rding to Laem mli [1 7], and were t ransferred onto 
ni t rocellulose paper 118] using a Trans-Blot apparatus (B io-Rad, Rich-
mond, California) . T he blot was cut in to strips and then incubated 
sequent ia lly wit h 5% normal rabbit serum , EKH4 antibody (u ndiluted 
culture supernatant), 1:20 diluted rabbit ant imouse lgG, and 1:100 
di lu ted mouse peroxidase-antiperox idase (PAP) (Polyscience, Inc., 
Warri ngton, Pennsylvania) each for 30 min . After each incubation , the 
blot was washed 3 t imes with 0.05 % Tween 20 in PBS, 10 min each. 
Fina lly, t he blot was incubated with substrate sol ution containi ng 4-
chlor-1-naphthol [19] for 2- 5 min , rin eel wit h wate r, and a ir-dried. 
For control , cytoplasmic proteins extracted from tissue cul tured normal 
rat fibrob lasts [20] were analyzed in the same manner. 
.. ~ ' ,. 
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F IG 1. Indirect immunoflu orescence 
sta ining of various ti ssues with EKH4 
antibody. a, Normal human skin. The 
lower laye r of epide rmis is sta ined posi-
t ive ly. b, A hair fo ll ic le. A strong cyto-
plas mic stai ning of kerati nocytes of the 
o uter root sheath is seen. c, An eccrine 
sweat gland. Myoepithelial ce lls (M) of 
the secretory portion a nd dermal duct 
ce ll s (D) a re sta ined. d, Normal human 
gingiva. Basa l cell laye r of the epitheliu m 
is strongly sta ined. Fai nt staining of the 
s uprabasal laye rs is also presen t. e, A 
longitudina l sec tion of normal human 
esophagus. Basal ce ll laye r is sta ined 
specifica lly.(, No rma l mouse bladder. All 
laye rs of the epithel ium are posit ive ly 
sta ined. Bars = 50 11111. 
' . ~ 
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RESULTS 
Immunofluorescence Study 
By indirect immunofluorescence technique, EKH4 ant ibody 
stained t he lower 2- 3 layers of t he normal epidermis in frozen 
sections (Fig 1a) . The sta ining intensity was strongest at t he 
basal cell laye r and decreased a few layers above the basal cell 
layer. Hair folli cles, sebaceous glands, sweat ducts, and myo-
ep it helial cells of sweat glands were also stained strongly in 
their cytop las m (Fig 1b,c). No cross- reaction with dermal com-
ponents, such as fibrobl asts, smooth muscles, nerves, endothe-
lia l ce lls, or infil trating cell s was noted. In the sections of oral 
mucosa EKH4 a ntibody stained basa l cell specifically with or 
without faint sta ining of suprabasallayers (Fig ld). Esophageal 
epithelium also showed basal cell laye r spec ific staining (Fig 
1e) . Mouse skin and mucosa showed similar staining to human 
t issues. Among mouse internal organs tested, bladder epithe-
lium showed posit ive staining of a ll t he layers (Fig 1/) . In 
FIG 2. Indi rect im munofluorescence staining of t issue-cul tured TL 
cells with EKH4 antibody. Wavy fil amentous meshwork is seen in the 
cytoplasm suggesting that tonofilaments a re stained. Bar= 20 I-'m. 
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thymus, epi t helial cells were stained hete rogeneously. Kidney 
showed weak staining in ductal structures and liver showed 
very weak sta ining in bile ducts. All t he norma l as well as 
t ransformed cells of nonep it helia l tissues tested were negative. 
Among t issue-cultured cells tested, all TL and SCC cells showed 
strong staining on the cytoplasmic filamentous network (F ig 
2) . Nonepithelial cell lines, such as fibroblast, melanoma, glio-
blastoma, and neuroblastoma failed to react with EKH4 anti -
body. In a stomach carcinoma ce ll line, 20-30% of the cells 
were stained positively. In breast cancer cell lines, most cells 
were negative but some cells showed weak positive staining 
(BT-20, 5- 10%; MCF-7, 2-5%). 
In fresh frozen sections of 23 BCEs, all t he tumor cells were 
stained strongly (Fig 3a) . In all cases, including sclerosing type, 
scattered tumor cells among connective t issue cells could easily 
be ident ified (Fig 3b ). There was no sta ining in the stroma. In 
the fresh t issue sections of 4 SCCs (Fig 4a) and one leukoplakia 
(Fig 4b ), EKH4 antibody also stained all the tumor cells 
whereas no stromal cells reacted. In some BCE and SCC 
sections, normal-looking, overlying epidermis was entirely 
stained by EKH4 antibody in addition to the basal cell layer. 
This expanded staining of the epidermis was also observed in 
all sections of psoriasis, gingiva with chronic inflammat ion , 
actinic keratosis, and some sections of seborrheic keratosis 
(Figs 5a, 6a). 
In cont rast to EKH4, AE1 monoclonal ant ikeratin antibody, 
which stains the basal ce ll layer in normal epidermis [6 ,7], 
showed suprabasal staining of epidermis in psoriasis, gingiva 
with chronic inflam mation, and seborrheic keratosis (Figs 5b, 
6b). AE1 antibody stained BCEs and SCCs weakly to moder-
ately with some variations in each tumor (Fig 7). Suprabasal 
sta ining patte rn with AE1 antibody was also observed in some 
normal-appearing overlying epidermis of BCE and SCC sec-
tions. The stainings of AE1 vs EKH4 in normal and diseased 
tissues are summarized in Table I. 
Jmmunoperoxidase Study 
By indirect immunoperox idase technique, EKH4 stained t he 
lower layers of normal ep idermis in fresh frozen sections as 
well as in alcohol-fixed , paraffin-embedded sections (Fig 8a,b ). 
FIG 3. Indirect immunof1uorescence 
sta in ing of a BCE with EKH4 antibody. 
a, Low-magnification picture shows t hat 
entire tumor nests are strongly stained. 
Note no staining in t he stroma. Bar = 
50 11m. b, High-magnification picture. 
Cytoplasmic staining of single tumor cell 
scattered into the dermis is clearly dem-
onstrated. Bar = 20 11m. 
FIG 4. a, Indirect immunofluores-
cence staining of a SCC with EKH4 an-
tibody. All the tumor cells are strongly 
sta ined. Bar = 50 111n. b, A leukoplakia. 
Ent ire transformed epithelia l cell layer 
including upper layers are positively 
stained with EKH4 antibody. Bar= 100 
!lin. 
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FIG 5. Indirect immunofluorescence 
sta ining of psori atic epidermis. a, EKH4 
sta ins entire epidermi s including basal 
cells . b, AEl stains suprabasal keratino-
cytes but does not tain basa l ce lls. ar-
rowheads, dermal-epidermal junction. 
Frc 6. Indirect immuno!luorescence 
staining of gingiva with chronic inflam -
m ation. a, E KH4 sta ins whole epi the-
lium including basa l ce lls. b, AEl stains 
s uprabasa l laye rs with some weak stain-
ing o n basa l ce lls. Bars = 50 J.Lil1. 
Fr c 7. Indirec t immunofluorescence staining of a BCE with AEl 
a n t ibody. Most of the tumor cells are stained only weakly. Bar = 50 
IJ.m. 
In fi xed t issues of 11 BCEs and 3 SCCs, a ll tumor ce lls were 
stained pos it ive ly (Fig 9a ). There was no difference in staining 
p atte rns betwen frozen sections and alcohol-fixed, pa raffin-
e mbedded sections. In t he sections obtained during Moh's 
s urge ry, a ll the tumor cell s were strongly stained wi t h EKH4 
a n t ibody (F ig 9b ). 
I mmunoblotting S tudy 
When ext racted kerat ins of living laye rs of epidermis were 
analyzed by S DS- PAGE, 4 major components of 50, 55-56, 58, 
and 65- 69 kd were obse rved (Fig 10, la ne 1) . Immunoblottmg 
a n a lysis us ing PAP staining showed that EKH4 a ntibody re-
acted predominant ly wi t h the 50 kd keratin (Fig 10, lane 2). In 
addi t ion , wea k reactions wi t h some small er keratins were oc-
casio nally noted (Fig 10, lane 2). EKH4 ant ibody did not react 
wit h cytoplasmic proteins including vimentin and actin from 
cul t ured rat fibroblasts (Fig 10, lanes 4, 5). 
DISCUSS ION 
In t his report, we presented a monoclonal antibody EKH4 
whic h reacts predominant ly with 50 kd keratin and stains only 
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the lower 2-3 layers of t he normal epidermis. This novel 
staining pattern of t he normal epidermis has not been described 
previously by any ant ikeratin ant ibody. According to direct 
analys is of keratins, 50 kd keratin was shown to exist in t he 
basal layer and persisted in suprabasal layers [6] . Howeve r, it 
was reported t hat an ant igen on thi s keratin is masked in the 
suprabasal layers in situ and cannot be detected by monoclona l 
antibody AEl [6]. Since EKH4 and AEl both recognize 50 kd 
keratin (AE1 also recognizes 56.5 kd keratin [21]) , we compared 
both ant ibodies in various sections to clarify whether AE1 and 
EKH4 react with t he same a nt igen. The resul ts showed t hat 
t here are clear differences in staining patterns between AEl 
and EKH4, i.e., (1) AEl stains only t he basal ce ll laye r (llayer) 
in normal epidermis whereas EKH4 stains t he lower 2- 3 laye rs 
(in some atrophic epidermis, EKH4 may show t he basal ce ll 
laye r specific staining [see Fig 9a]); (2) AEl shows suprabasa l 
staining pattern in benign hyperproliferative diseases including 
psoriasis, seborrheic kera tosis, gingiva wi t h chronic inflam-
mation, and some normal-appearing overlying epidermis of 
cutaneous tumors, whereas EKH4 sta ins in t hese condi t ions 
whole epidermis including t he basal layer; (3) AEl stains 
cutaneous epithelial t umor ce lls weakly and irregu larly (Fig 7) 
[7], whereas EKH4 sta ins them strongly and homogeneously; 
(4) AEl does not stain skin amyloid whereas EKH4 stains it 
strongly [22]. These results suggest t hat EKH4 and AE l rec-
ognize different ant igenic dete rminants on t he 50 kd keratin 
polypeptide. Since direct analysis has shown t hat 50 kd keratin 
exists t hroughout the epidermal layers [6], staining differences 
between these two antibodies could be due to a different degree 
of mas king of t he an tigens in situ [6]. 
Immunohistochemically, EKH 4 ant ibody recognized all t he 
skin epi theli al tumors we tested. The major keratin polypep-
t ides of t hese tumors are similar to t hat of the pilosebaceous 
uni t which ranges from 46-58 kd including 50 kd keratin [23-
26]. Since EKH4 ant ibody reacts wi t h 50 kd and probably with 
some smaller keratins, it is easily understood why EKH4 ant i-
body reacts with a ll the BCEs and SCCs. In contrast to rela-
tively selective sta ining of normal epidermis, a ll t he tumors 
exhibi ted di ffu se stainin g. This difference is probably due to a 
lack of termina l differentia tion or maturation of keratinocytes 
in t he tumors. In many disorders of incomplete different iation 
of keratinocytes such as pso riasis, t he ent ire epidermis also 
beca me positive wi th th is ant ibody. 
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App lication of po lyclonal antikera t in antisera in the di ag-
nosis of ep ithelia l tumo rs has bee n reported [27- 31 ]. fn Moh's 
microscopica lly controlled surgery, identi fi cation of s ingle tu-
mor cell s scatte red in to stromal coinpo nents, such as in t he 
cases of morphea type BCEs or disseminating SCCs, is espe-
cia lly di ffi cul t with routine hematoxylin and eos in sta ining 
a lone. Although EKH4 is not suitab le to different iate ep idermal 
appendages from t umor nests, it can clea rly ident ify t he single 
tumor ce ll admixed wit h stromal ce ll s (see Fig 3b ). In t hi s 
respect, app lication of EKH4 a nt ibody to Moh 's surgery is 
valuable until tumor cell specific a nt ibody is ava il able in the 
future. S ince EKH4 a ntibody ca n be used on a lcohol -fixed, 
TABLE 1. Summary of immunuflu.orescence staining: EKH4 us AI!.' I 
EK H4 antibody AEl antibody 
No rmal tis.w.e., 
Epiderm is Lowest 2- 3 laye rs Basal laye r 
Hair follicle, sweat duct, All cells Basal laye r 
sebaceous gla nd 
Sweat gland Myoep ithelia l ce lls All ce ll s 
Oral mucosa Basal layer Basal laye r 
Esophageal epithelium Basal laye r Basal laye r 
Bladder epithelium All laye rs All laye rs 
Thymus Epithelial ce lls Ep ithelia l ce lls 
Kidney, li ve r Ducts Ducts 
Diseases 
BCE Strong sta ining, Weak stain -
a ll cells ing, a ll ce lls 
(heterogene-
ous in some 
cases) 
sec Strong sta ining, Wea k to mod-




Leu koplakia Strong sta inin g, 
a ll ce lls 
Epidermis ove rl yin g tu- Entire epidermis Supra basal 
mors laye rs 
Psorias is Enti re epiderm is Suprabasa l 
laye rs 
Actinic keratos is Entire epidermis Suprabasal 
layers 
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paraffin -embedded t issues, retrospective tumor study us ing 
fil ed blocks is a nother a rea of application. 
Despite a large number of po lyc lona l a ntikerati n ant ibodies 
developed in t he past decade, only a few well -defin ed, we ll -
cha racte rized monoclonal ant.ikeratin antibod ies have bee n re-
ported [6,32- 34]. All of t hese ant ibodies have different cha r-
acte ri stics when compared wi t h EKH4 ant ibody. Compa rative 
studies of t hese, including our EKH4 a nt ibody, will signifi -
1 2 3 4 5 
F IG 10. Binding of EKH4 ant ibody to epidermal keratins separated 
by 808-PAGE. Tris- insoluble cytoplasmic proteins from living layers 
of human epidermis (lanes 1 and 2) a nd cytoplasm ic extracts from 
cul tured rat fibroblasts (lanes 4 and 5) a re separated by 12.5 % poly-
ac rylamide gels. Lanes I and 3 (standard), and 4 a re sta ined d irectly 
wi th Coomass ie blue. Lanes 2 and 5 are EKH4 sta ining of ni t rocellulose 
papers onto whic h proteins a re electrophoretically transferred. EKH4 
bound to 50 kd keratin but did not bind to larger keratins (lane 2). 
There a re minor bands betwee n 40- 48 kd which are faintly stained 
wit h EKH4. EKH4 did not bind to fibroblastic proteins (lane 5) 
including viment in (58 kd) and actin (43 kd) (lane 4). Molecular weight 
standards: phosphorylase B, bovine serum albumin , ovalbumin : and 
carbonic anhydrase (lane 3). 
F IG 8. a, Indirect immunoperoxidase 
sta ining of normal human skin with 
EKH4 antibody in an alcohol-fixed, par-
affin -embedded section. Lower 2-3 lay· 
ers of the epidermis a re stained. b, High-
magnification picture of different a rea. 
The lower 2-3 laye rs a re stained. Bars = 
50 Jlll1 . 
F IG 9. Indirect immunoperoxidase 
stai ning of BCEs with EKH4 antibody. 
a, An alcohol-fixed, paraffin· embedded 
section . Ent ire tumor nests a re sta ined 
positive ly. In t he epidermis in the right 
half, where it is atrophic, only the basal 
layer is stained. b, A fresh frozen section 
obta ined during Mob's surgery. The tu-
mor nests are strongly sta ined and a re 
eas ily identified. Bars = 50 11m. 
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cantly co nt ri bute to t he clarificat ion of in vivo di stribution of 
various ·pec ies of keratin in the normal a nd abnormal tissues. 
Addendum 
Two-dim ensiona l PAGE revea led t hat EKH4 recognizes 50 
kd- pl 7 and 50 kd - pJ 6.3 keratins o f the normal epidermis. 
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